Carvedilol Tablet, Film Coated
Product Images NDC 71335-2474

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 71335-2474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A line graph comparing mortality percentage over 21 months between Carvedilol and placebo groups. The x-axis represents time in months, and the y-axis shows percentage mortality. Two lines show differing mortality rates, with Carvedilol consistently lower than placebo. A p-value of 0.0014 indicates statistical comparison.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A forest plot chart illustrating hazard ratios for various patient subgroups, including gender, age groups, race, diabetic status, ischemic status, heart rate, systolic blood pressure categories, and spironolactone use. Each subgroup is represented by a point estimate with horizontal confidence intervals, compared against a reference hazard ratio of 1.0.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A line graph comparing percentage mortality over 24 months between patients treated with Carvedilol versus placebo. The x-axis represents time in months, and the y-axis shows percentage mortality. Two curves indicate mortality trends, with Carvedilol showing lower mortality than placebo, and a significance value (P = 0.03).*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
A forest plot chart depicting hazard ratios with confidence intervals for various subgroups of patients classified by age, sex, timing post-myocardial infarction, beta-blocker use, Killip class, thrombolytic therapy, PTCA for MI, congestive heart failure history, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure. Two columns of forest plots indicate comparative hazard ratios among these subgroups.*
FDA Label Image

Label (Lbl713352474)

Label (Lbl713352474)
Carvedilol Tablets, USP 25 mg film-coated tablets, packaged by Bryant Ranch Prepack and manufactured by Beximco Pharmaceuticals Ltd. The label includes storage instructions, NDC 71335-2474-1, a quantity of 100 tablets, and a note to keep drugs out of reach of children. It also provides a pharmacist link for patient package inserts.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of Carvedilol showing its molecular framework including aromatic rings, hydroxyl, methoxy, and amine functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.